Australia
· Delayed Price · Currency is AUD Microba Life Sciences Company Description
Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.
It operates through two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome.
In addition, it offers MetaPanel, a metagenomic test for pathogen detection; MetaXplore, a diagnostics under the brand Co-Biome and MetaXplore; non-diagnostic personal and research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel disease, and autoimmune diseases, as well as microbiome databank.
Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.
| Country | Australia |
| Founded | 2017 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| CEO | Luke Reid |
Contact Details
Address: 324 Queen Street Brisbane, 4000 Australia | |
| Phone | 61 13 0097 4621 |
| Website | microba.com |
Stock Details
| Ticker Symbol | MAP |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000209868 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Dr. Luke Reid | Chief Executive Officer |
| Prof. Gene Tyson | Co-Founder and Non-Executive Director |
| James Heath | Chief Financial Officer and Company Secretary |
| Prof. Philip Hugenholtz | Co-Founder and Chair of Scientific Advisory Board |
| Prof. Lutz Krause | Chief Scientific Officer |
| Drew Webb | Chief Marketing Officer |
| Prof. Trent Munro | Senior Vice President of Therapeutics |
| Dr. Nicola Angel | Head of Laboratory Operations |
| Bernie Woodcroft | Senior Vice President of Platform Solutions |
| Dr. David Wood | Head of Bioinformatics Operations |